Pfizer (NYSE:PFE) announced its intention to sell its entire residual shareholding in Haleon plc, reflecting a divestment ...

The latest trading day saw Pfizer (PFE) settling at $25.60, representing a -0.43% change from its previous close.

Pfizer Inc. (PFE) agreed to sell its remaining stake worth $3.3 billion in Haleon PLC (HLN), marking its exit from the UK-based consumer ...

Representative Julie Johnson (D-Texas) recently sold shares of Pfizer Inc. (NYSE:PFE). In a filing disclosed on March 12th, the Representative disclosed that they had sold between $1,001 and $15,000 ...

Pfizer PFE underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Shah now forecasts that the biopharmaceutical ... rating and a $25.00 price target on the stock. Citigroup dropped their price target on shares of Pfizer from $30.00 to $29.00 and set a “neutral ...

I hope you weren’t expecting much movement in the stock following ... often try to price in anticipated catalysts even before they could materalize. And given that Pfizer has already ...

The stock received such an upgrade quite recently, less than a month ago. The share price has grown ... a negative catalyst also if PFE fails to surpass consensus forecasts. The revenue surprise ...

Protalix saw record revenue growth in 2024, driven by increased sales to Chiesi, Pfizer, and Brazil. The company aims to start a Phase 2 trial for PRX-115 in 2025. The Dow Jones closed lower by ...

Analysts estimate Pfizer will grow earnings by almost 14% annually over the next three to five years. So far, investors haven't noticed. The stock trades near its lowest price in over a decade ...

Adobe (NASDAQ; ADBE) recently announced its fiscal first quarter results for the period ending February 2025, reporting ...